Craig C. Hopkinson
CIK 1730048 · EVP R&D, Chief Medical Officer · last filed 2026-08-03
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$3.36M
Companies
2
Total Filings
77
Lifetime Open-Market Net
-$24.32M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ALKS | EVP R&D, Chief Medical Officer | 69,389 | $48.37 | $3.36M | -$24.32M | 54 | 2026-08-03 |
| ALBIREO PHARMA, INC. (ALBO) Delisted | Director | 10,495 | $44.15 | $463.4K | $0 | 2 | 2023-03-02 |
Recent Filings · Page 4 of 8
77 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-02-28 | ALKS | Mixed | +3,817 | -$106.1K | EDGAR |
| 2025-02-25 | ALKS | Mixed | +11,102 | -$313.1K | EDGAR |
| 2025-02-20 | ALKS | Mixed | +4,946 | -$141.8K | EDGAR |
| 2025-02-14 | ALKS | Mixed | −5,725 | -$3.59M | EDGAR |
| 2025-02-13 | ALKS | Notice (144) | −144,419 | -$5.13M | EDGAR |
| 2025-02-12 | ALKS | Notice (144) | −204,921 | -$6.72M | EDGAR |
| 2025-02-07 | ALKS | Mixed | +19,310 | -$473.5K | EDGAR |
| 2025-01-31 | ALKS | Mixed | −3,286 | -$1.07M | EDGAR |
| 2025-01-30 | ALKS | Notice (144) | −100,918 | -$3.23M | EDGAR |
| 2024-12-09 | ALKS | Notice (144) | −61,151 | -$1.96M | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.